Ventyx Biosciences Inc (NASDAQ: VTYX) kicked off on Tuesday, down -12.32% from the previous trading day, before settling in for the closing price of $1.38. Over the past 52 weeks, VTYX has traded in a range of $0.78-$5.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -4.71%. With a float of $62.53 million, this company’s outstanding shares have now reached $71.13 million.
In an organization with 82 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ventyx Biosciences Inc is 12.13%, while institutional ownership is 76.61%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -4.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.42% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Take a look at Ventyx Biosciences Inc’s (VTYX) current performance indicators. Last quarter, stock had a quick ratio of 17.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.99, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.95 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.04 million. That was inferior than the volume of 1.26 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 66.32%. Additionally, its Average True Range was 0.12.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 18.92%, which indicates a significant decrease from 41.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.03% in the past 14 days, which was higher than the 81.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2627, while its 200-day Moving Average is $1.9541. However, in the short run, Ventyx Biosciences Inc’s stock first resistance to watch stands at $1.3633. Second resistance stands at $1.5167. The third major resistance level sits at $1.6733. If the price goes on to break the first support level at $1.0533, it is likely to go to the next support level at $0.8967. The third support level lies at $0.7433 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
The company with the Market Capitalisation of 86.10 million has total of 71,161K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -135,120 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -29,350 K.
